Stay updated on DCC-3014 in Advanced Tumors & Tenosynovial Giant Cell Tumor Clinical Trial
Sign up to get notified when there's something new on the DCC-3014 in Advanced Tumors & Tenosynovial Giant Cell Tumor Clinical Trial page.

Latest updates to the DCC-3014 in Advanced Tumors & Tenosynovial Giant Cell Tumor Clinical Trial page
- Check6 days agoChange DetectedThe record for the vimseltinib Phase 1/2 study is now accessible, with details on eligibility, participating locations, treatment design, and outcome measures. It also shows that the study is active but no longer recruiting.SummaryDifference61%

- Check13 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedA banner announces that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check27 days agoChange DetectedThe footer's displayed site revision changes from v3.7.1 to v3.7.2, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe site revision marker in the page footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check48 days agoChange DetectedThe 403 error page content and related HTML elements were removed, indicating the page now loads the actual study details instead of an error. This restores access to the study information.SummaryDifference0.5%

Stay in the know with updates to DCC-3014 in Advanced Tumors & Tenosynovial Giant Cell Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DCC-3014 in Advanced Tumors & Tenosynovial Giant Cell Tumor Clinical Trial page.